Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy

Exclusion Criteria

• •Presence of proliferative diabetic retinopathy features including vitreous hemorrhage or optic disc or retinal neovascularization
• •History of retinal laser photocoagulation
• •Tractional retinal detachment involving the macula
• •Evidence of neovascularization of angle on examination
• •Macular edema due to a cause other than DME
• •Any ocular condition which may change visual acuity during the study
• •History of intravitreal injection of anti-vascular endothelial growth factor agent in past 3 months
• •History of any use of intravitreal corticosteroid
• •History of major intra-ocular surgery except cataract surgery in the past 6 months
• •History of thromboembolic every in the past 3 months